Novel CCR5 antagonists for the treatment of HIV infection: a review of compounds patented in 2006 – 2008

Author： Yang Hanbiao   Rotstein David M  

Publisher： Informa Healthcare

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.20, Iss.3, 2010-03, pp. : 325-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CCR5 antagonists for the treatment of HIV

By Schmitz Jens  

PHARMAKON, Vol. 2, Iss. 4, 2014-07 ,pp. : 277-282

Govi-Verlag

Access to resources Recommend Favorite

Novel N-methyl-d-aspartate receptor antagonists: a review of compounds patented since 2006

By Koller Manuel   Urwyler Stephan  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 12, 2010-12 ,pp. : 1683-1702

Informa Healthcare

Access to resources Recommend Favorite

Orexin receptor antagonists: a review of promising compounds patented since 2006

By Coleman Paul J   Renger John J  

Expert Opinion on Therapeutic Patents, Vol. 20, Iss. 3, 2010-03 ,pp. : 307-324

Informa Healthcare

Access to resources Recommend Favorite

Treatment of HIV infection with the CCR5 antagonist maraviroc

By Kromdijk Wiete   Huitema Alwin DR   Mulder Jan Willem  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 7, 2010-05 ,pp. : 1215-1223

Informa Healthcare

Access to resources Recommend Favorite

Patented TGR5 modulators: a review (2006 – present)

By Gioiello Antimo   Rosatelli Emiliano   Nuti Roberto   Macchiarulo Antonio   Pellicciari Roberto  

Expert Opinion on Therapeutic Patents, Vol. 22, Iss. 12, 2012-12 ,pp. : 1399-1414

Informa Healthcare

Access to resources Recommend Favorite